Dupilumab Asthma ADVANTAGE-EU: Real-World Evidence on the Association Between Dupilumab and Use of Corticosteroid and Asthma Exacerbations in Patients With Severe Asthma in Europe

被引：0

作者：

Bourdin, A. ^{[1
]}

Canonica, G. ^{[2
]}

Virchow, J. ^{[3
,4
]}

Jacob-Nara, J. ^{[5
]}

Borsos, K. ^{[5
]}

Stanford, R. H. ^{[6
]}

Pandit-Abid, N. ^{[5
]}

Wang, Z. ^{[7
]}

Soler, X. ^{[7
]}

Huynh, L. ^{[8
]}

Kalia, S. ^{[8
]}

Duh, M. ^{[8
]}

Cheng, W. ^{[5
]}

机构：

[1] Univ Montpellier, CHU Montpellier, Dept Resp Dis, Montpellier, France

[2] IRCCS, Humanitas Clin & Res Ctr, Personalized Med Asthma & Allergy, Milan, Italy

[3] Univ Med, Dept Pneumol, Rostock, Germany

[4] Univ Med, Intens Care Med, Rostock, Germany

[5] Sanofi, Cambridge, MA USA

[6] AESARA Inc, Chapel Hill, NC USA

[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[8] Anal Grp Inc, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6698

引用

页数：3